Dr. Brian Shirts discusses ConnectMyVariant and the importance of connecting individuals with the same cancer variants.
All in Scientist
#172 PhenoTips: Advances in Rare Disease Diagnosis
Drs. Stephen Kingsmore, Marshall Summar, and Ellen Thomas join Dr. Pawel Buczkowicz to discuss the diagnostic odyssey in this installment of the PhenoTips Speaker Series.
#171 Farber Disease with Aceragen
In honor of Rare Disease Month we explore Farber Disease with Dr. Alex Solyom and Katie Crosby of Aceragen.
#170 Mitochondrial Disorders with Alejandro Dorenbaum
Investigational therapies for primary mitochondrial myopathy are discussed with Dr. Alejandro Dorenbaum in honor of rare disease month.
#169 Cytogenomics with Phase Genomics
Next generation cytogenomic applications in the reproductive genetics and oncology spaces are explored with Dr. Ivan Liachko and Dr. Stephen Eacker.
#168 Polygenic Risk Scores with Giordano Bottà
Allelica CEO and Co-Founder explains the power of PRS to assess people’s risk of common diseases.
#167 PhenoTips: Future of Cancer Genetics
Dr. Banu Arun and Dr. Mark Robson discuss how to prepare practitioners for the future of cancer genetics in this installment of the PhenoTips Speaker Series.
#165 Sequencing for Cancer Risk with Sandra Balladares
Scientist and breast cancer survivor explores how to utilize Illumina’s sequencing technology to assess inherited cancer risk.
#164 Parkinson’s Disease with the Parkinson’s Foundation
Representatives from the Parkinson’s Foundation and the Hispanic Parkinson’s Advisory Council explore Parkinson’s disease including diversity in genetic research.
#158 Mark Kiel on ALS Genetics
The Chief Science Officer and Co-Founder of Genomenon shares his insight on the genetics of ALS.
#156 Rich Horgan on Duchenne Muscular Dystrophy (DMD)
The Founder and President of Cure Rare Disease discusses treatments for Duchenne Muscular Dystrophy.
#154 Kenneth Kovan & David Berd on Haptenized Vaccines
BioVaxys’ Kenneth Kovan and Dr. David Berd discuss vaccine platforms for viral infections and cancers.
#153 Dayan Goodenowe on Dementia
Dr. Dayan Goodenowe, Founder, President, & CEO of Prodrome Sciences, shares about biomarkers for dementia & Alzheimer’s disease.
#151: Richard Michelmore and Brad Pollock on COVID-19 Variants
COVID-19 variant genotyping is explored with the Director of the UC Davis Genome Center and Healthy Davis Together project.
#150 Euan Ashley and Stephen Quake on The Genome Odyssey
Dr. Quake was the fifth person in the world to have their genome sequenced and Dr. Ashley led the team to decipher the code.
#148 CF Series: Shuling Guo on Pharmaceuticals
Ionis’ drug discovery efforts in cystic fibrosis and the applications of antisense medicine.
#146 Jo Bhakdi on Whole Exome Sequencing
Quantgene’s Founder and CEO explains whole exome sequencing including the technology, cost, which disorders can be diagnosed, and the possible future uses.
#145 Greenwood Genetic Center on Epigenetics
Dr. Ray Louie and Genetic Counselor Kellie Walden explore epigenetics including conditions and testing.
#144 Orion Buske on Genomic Digital Tools
Part two of our telehealth series, Phenotips CEO explores digital tools in genomics.
#142 Barbara Fortini on Genomic Data Analytics
Program Director for Keck Graduate Institute’s Master of Science in Human Genetics and Genomic Data Analytics program shares the growing career opportunities in the field.